CPT1A and melanoma: The tumor-derived Wnt5 ligand can activate β-catenin signaling in TADC, which upregulates PPARγ to induce Carnitine Palmitoyltransferase 1A (CPT1A)-driven FAO in a murine melanoma model (Zhao et al., 2018a).